In preparation for potential new product launches, Moderna has selected Ester Banque as chief commercial officer and expanded the role of president Stephen Hoge.
→ In preparation for potential new product launches, Moderna has selected Ester Banque as chief commercial officer and expanded the role of president Stephen Hoge …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. | As…
DUBAI: Moderna appointed a new chief commercial officer and widened its president’s role to oversee certain franchises, the…
Moderna expands leadership roles and commercial operations as it prepares for multiple vaccine launches and key clinical…
Thomas Lampron formally announced on LinkedIn this week that he is 'thrilled to join the powerhouse team at Revolution Medicines'…
Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialog with the FDA—but…
UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
Moderna announces executive changes ahead of potential launches
Moderna Strengthens Commercial Strategy As Pipeline Advances - Moderna (NASDAQ:MRNA)
FDA appears open to Moderna's flu vaccine ahead of adcomm
Sanofi swaps R&D leaders; Merck’s Prometheus deal pays dividends
Moderna CEO: ‘I worry deeply about bioterrorism’
ARCH-launched Neumora stops depression program
Moderna to Host Investor Event - Science Day
Sanofi names new R&D head as it tries to jumpstart pipeline
FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)
